Literature DB >> 28066653

Authors' response to commentaries on rosuvastatin for delirium and cognitive impairment in sepsis-associated acute respiratory distress syndrome.

Victor D Dinglas1, Elizabeth Colantuoni2, E Wesley Ely3, Catherine L Hough4, Peter E Morris5, Pedro A Mendez-Tellez6, Amy W Wozniak2, Ramona O Hopkins7, Dale M Needham8.   

Abstract

Entities:  

Year:  2016        PMID： 28066653      PMCID： PMC5179448          DOI： 10.21037/jtd.2016.11.53

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  8 in total

1.  Statins for delirium in ICU patients: a negative trial but a positive step.

Authors:  Peter W Lange; Andrea B Maier
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

2.  Statistical methods for evaluating delirium in the ICU.

Authors:  Elizabeth Colantuoni; Victor D Dinglas; E Wesley Ely; Ramona O Hopkins; Dale M Needham
Journal:  Lancet Respir Med       Date:  2016-06-02       Impact factor: 30.700

3.  Association of rosuvastatin and delirium in severe sepsis with acute respiratory distress syndrome.

Authors:  Leili Pourafkari; Nader D Nader; Jahan Porhomayon
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

Review 4.  Outcome Measurement in ICU Survivorship Research From 1970 to 2013: A Scoping Review of 425 Publications.

Authors:  Alison E Turnbull; Anahita Rabiee; Wesley E Davis; Mohamed Farhan Nasser; Venkat Reddy Venna; Rohini Lolitha; Ramona O Hopkins; O Joseph Bienvenu; Karen A Robinson; Dale M Needham
Journal:  Crit Care Med       Date:  2016-07       Impact factor: 7.598

5.  One-year outcomes of rosuvastatin versus placebo in sepsis-associated acute respiratory distress syndrome: prospective follow-up of SAILS randomised trial.

Authors:  Victor D Dinglas; Ramona O Hopkins; Amy W Wozniak; Catherine L Hough; Peter E Morris; James C Jackson; Pedro A Mendez-Tellez; O Joseph Bienvenu; E Wesley Ely; Elizabeth Colantuoni; Dale M Needham
Journal:  Thorax       Date:  2016-03-02       Impact factor: 9.139

Review 6.  Progress on core outcome sets for critical care research.

Authors:  Bronagh Blackwood; John Marshall; Louise Rose
Journal:  Curr Opin Crit Care       Date:  2015-10       Impact factor: 3.687

7.  Rosuvastatin versus placebo for delirium in intensive care and subsequent cognitive impairment in patients with sepsis-associated acute respiratory distress syndrome: an ancillary study to a randomised controlled trial.

Authors:  Dale M Needham; Elizabeth Colantuoni; Victor D Dinglas; Catherine L Hough; Amy W Wozniak; James C Jackson; Peter E Morris; Pedro A Mendez-Tellez; E Wesley Ely; Ramona O Hopkins
Journal:  Lancet Respir Med       Date:  2016-01-29       Impact factor: 30.700

8.  Multinational development and validation of an early prediction model for delirium in ICU patients.

Authors:  A Wassenaar; M van den Boogaard; T van Achterberg; A J C Slooter; M A Kuiper; M E Hoogendoorn; K S Simons; E Maseda; N Pinto; C Jones; A Luetz; A Schandl; W Verbrugghe; L M Aitken; F M P van Haren; A R T Donders; L Schoonhoven; P Pickkers
Journal:  Intensive Care Med       Date:  2015-04-18       Impact factor: 17.440
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.